A New Era in the Fight Against Scleroderma

A New Era in the Treatment For

Scleroderma

We provide innovative medical solutions based on scientific discoveries for people with systemic sclerosis, aiming to enhance their health.

Begin your journey to a healthier life today!

About
Scleroderma

Scleroderma, also called systemic sclerosis, is a progressive chronic autoimmune disease that not only affects the skin but can also damage connective tissue in vital organs such as the heart, lungs, and kidneys, as well as the musculoskeletal, circulatory, and digestive systems.

Effective treatment is essential to prevent complications.

About

These specialized cells, derived from umbilical cord (UC) tissue, have the ability to transform into various types of tissue, making them crucial for regenerating damaged tissues. They can form tissues such as skin, heart, lungs, cartilage, and more, showcasing their versatility in regenerative medicine.

MSCs cells have a significant regenerative potential.

Umbilical cord-derived MSCs and
Scleroderma

Research is revolutionizing the approach to scleroderma. Some of the benefits and advantages our treatment offers include:

UC-MSC provide significant benefits for scleroderma patients.

Research articles about UC-MSCs

We provide care to people from anywhere in the world.

About me

I am Dr. Mikel, a medical doctor and a Ph.D. in science. My mission is to help people with rheumatic diseases, such as scleroderma, manage their symptoms and improve their quality of life (see bio).

"In the relentless pursuit of scientific knowledge, medicine continuously evolves, revealing increasingly promising therapies to address the vast spectrum of diseases that challenge our existence."

Dr. Mikel De Uranga